{"name":"Precirix","slug":"precirix","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxQNXpOU3k1VDBhUW9rWHVkekxaU3kyTXZOMUwzeHplUTE5YzRwaWw3a3BkS1JIMmhhVVphZ3ppd3RZcGN5OVpPWGtTamYwSUZSLWJGcDVPM1FEaXRZRTFyZzktMzBSWkk3dU1FT1c1WGhwSXBIcVVZRTJkblRTT0ZOM25n?oc=5","date":"2025-07-10","type":"trial","source":"Oncology Pipeline","summary":"Actithera hopes to do FAP differently | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline","headline":"Actithera hopes to do FAP differently | ApexOnco - Clinical Trials news and analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNMFFrcUdsV1JYSjNDUDVWa29BcnBHQ3VUY18yWU9IUWhYTEo1d1lBU2tHeEFuaHYybktBY3ZYRXlKRzlrUE9HVFFoWHphTldBbElnUDhNMGhnWXJzRnNXWnNzQ1FWYXdhQ1lRY3d3bGdmaHc3N09RalBVOTBjaVBQanlNb1dKWXVrNmd0cF9tajA4a0ZGYnVKb2JSdw?oc=5","date":"2024-05-08","type":"pipeline","source":"Taylor Wessing","summary":"Biotech acquisition trend: radiopharmaceuticals - Taylor Wessing","headline":"Biotech acquisition trend: radiopharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxPTFNqUlNPSWk4RFhDdWxTRWwySEkzd0lrZ2pJYzY3UWdILVgxbnFQd0xFOEowTTY2QXVibWhQSEVkQzl0N1JFR3B1UHkxSDVPVkZ6THMyNmN3bnpVeWc4Q2trVlJ5V3o3ZExSeFRWQjF6YS1XR2Q3Vmx5YUZIenlZRERuSXI0TmZpdWNOc2dlZ2tiOEJRQ3c?oc=5","date":"2022-03-16","type":"pipeline","source":"pharmaphorum","summary":"Belgium's Precirix raises €80m to fund radiopharma aspirations - pharmaphorum","headline":"Belgium's Precirix raises €80m to fund radiopharma aspirations","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxNa0JfXzN4SVMxZnBKWEZYZ0k4OXcwcEVNTHpQZ2RjamVaN1Z0V0d0emVONU4wemtZSU8yQzVsUXFkbjMtSTFQVlVXMmhXZ2g2ZEs4R3g4TXQyVjJhU0VBc2dmeXFXNGJOUnpacVJZM1BrZXQ0aXJva1AwTmxnNkFobXEwSnp2VzZQcG52dTJhS3JxVlZ3Ul9zdWduMkR2RHNYSWZnYjBGODNSZFFVV2dCbmU3Z0FOSDlOaVhTTVJzTEthQQ?oc=5","date":"2022-03-16","type":"pipeline","source":"Fierce Biotech","summary":"Belgian biotech Precirix snags $88M to bankroll radiopharmaceuticals in HER2-positive cancers - Fierce Biotech","headline":"Belgian biotech Precirix snags $88M to bankroll radiopharmaceuticals in HER2-positive cancers","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}